Randomized Clinical Trial of Long-Acting Somatostatin for Autosomal Dominant Polycystic Kidney and Liver Disease

There are no proven, effective therapies for polycystic kidney disease (PKD) or polycystic liver disease (PLD). We enrolled 42 patients with severe PLD resulting from autosomal dominant PKD (ADPKD) or autosomal dominant PLD (ADPLD) in a randomized, double-blind, placebo-controlled trial of octreotid...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hogan, Marie C., Masyuk, Tetyana V., Page, Linda J., Kubly, Vickie J., Bergstralh, Eric J., Li, Xujian, Kim, Bohyun, King, Bernard F., Glockner, James, Holmes, David R., Rossetti, Sandro, Harris, Peter C., LaRusso, Nicholas F., Torres, Vicente E.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Nephrology 2010
Assuntos:
Clinical Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC2900957/
https://ncbi.nlm.nih.gov/pubmed/20431041
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1681/ASN.2009121291
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados